RxDoctor Payments Data

Mark Birmingham, DPM

Foot & Ankle Surgery · Boulder, CONPI 1396913117

Payments from drug & device makers

$6,509in general payments, 2019–2025

Across 89 payments — averaging $73.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gemini Mountain Medical, LLC$3K
  • Arthrex$877
  • Paragon 28, Inc.$512
  • Integra Lifesciences Corporation$437
  • Smith+Nephew$249
  • Johnson & Johnson$209
  • plus $2K from 23 others

What the payments were for

  • Travel & lodging$4086%
  • Food & beverage$3,31651%
  • Education$2,78543%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,509 in reported general payments places this provider in the 65th percentile of 181 foot & ankle surgery providers in Colorado.

See all foot & ankle surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$188,984
Medicare patients
581
Services billed
1,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole14$21,258
Ciclopirox26$1,070
Gabapentin72$789
Terbinafine Hcl32$765
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$312
Diclofenac Sodium47$277
Oxycodone Hcl11$50

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$46$21,25814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 181 foot & ankle surgery providers in Colorado.

Other foot & ankle surgery in Boulder

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →